Concepedia

W. HOEKSTRA

WH

5

Publications

382

Citations

5

H-Index

1985

Active since

Affiliations

Viamet Pharmaceuticals (United States)(Current)

W. HOEKSTRA is an author at Viamet Pharmaceuticals (United States) specializing in microbiology, clinical microbiology, and medicine.

Top concepts

Publications per year

1985–2016

5

Publications

5

The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme

Andrew G. S. Warrilow, Claire M. Hull, Josie E. Parker et al. · Antimicrobial Agents and Chemotherapy · 2014 · 162 citations · Full text

Efficacy of the Clinical Agent VT-1161 against Fluconazole-Sensitive and -Resistant Candida albicans in a Murine Model of Vaginal Candidiasis

Edward P. Garvey, W. HOEKSTRA, Robert J. Schotzinger et al. · Antimicrobial Agents and Chemotherapy · 2015 · 80 citations · Full text

, , +23

Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong <i>In Vitro</i> Activity against Candida glabrata and C. krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal Compounds

Wiley A. Schell, Alexander M. Jones, Edward P. Garvey et al. · Antimicrobial Agents and Chemotherapy · 2016 · 72 citations · Full text

VT-1161 Dosed Once Daily or Once Weekly Exhibits Potent Efficacy in Treatment of Dermatophytosis in a Guinea Pig Model

Edward P. Garvey, W. HOEKSTRA, William R. Moore et al. · Antimicrobial Agents and Chemotherapy · 2015 · 57 citations · Full text

The IncI Plasmids R144, R64 and ColIb Belong to One Exclusion Group

R. A. Hartskeerl, E.M. Zuidweg, M. VAN GEFFEN et al. · Microbiology · 1985 · 11 citations

, , +17

Rows per page

1–5 of 5